Brought to you by:
Positive data show novel delayed-release diameter reduction technique in construction of PMEGs is viable
A novel physician-modified endograft (PMEG) technique for the treatment of thoracoabdominal and complex abdominal aortic aneurysms (TAAA and AAA) involving delayed-release diameter reduction to aortic size and shape—allowing for sequential target vessel cannulation—is safe and effective, according to a new…
TAMBE and TBE: Evolving experiences and piecing together channels of inquiry
New findings chronicling progress with both the Gore Excluder thoracoabdominal branch endoprosthesis (TAMBE)— approved by the Food and Drug Administration (FDA) last year—and Gore Tag thoracic branch endoprosthesis (TBE), which recently acquired a new indication for use in aortic zones…
Patient-facing literature from SVS found to exceed recommended reading level
A readability analysis of 15 publicly available patient education materials from the SVS found that all but three exceeded the 8th-grade reading level, the threshold at which the average adult in the U.S. reads. Additionally, all 15 breached the 6th-grade…
Mechanical thrombectomy system for AV access shows promise, study shows
A retrospective analysis of 64 patients treated between 2022 and 2025 using a novel mechanical thrombectomy system to treat dialysis access thrombus showed function was restored in 91% of those treated. Data from the study of the InThrill system (Stryker/…
STORM-PE finds mechanical thrombectomy superior to anticoagulation alone
The use of mechanical thrombectomy, specifically computer-assisted vacuum thrombectomy (CAVT) using the 16Fr Lightning Flash system (Penumbra), with anticoagulation achieves superior reduction in right heart strain compared to anticoagulation therapy alone in patients with acute intermediate-high-risk pulmonary embolism (PE). This…
SVS Foundation set to launch Enrico Ascher Vascular Innovation Institute at VAM 2026
The Society for Vascular Surgery (SVS) Foundation will formally establish the Enrico Ascher Vascular Innovation Institute as a new entity under its research and innovation portfolio, following generous support from the Ascher family. Set to launch at the 2026 Vascular…
Closer to the goal: Shoring up data behind breakthrough imaging technology that plots a radiation-free future in new RCT
UMass chief peers down the lens of an if-not radiation-free complex aortic procedural future, then one in which the methods of today will look positively quaint. “I say this a lot,” says Andres Schanzer, MD, “but I think there is…
A global concern: WFVS seeks to level up vascular education in every corner of the world
WFVS secretary general details how the organization has evolved in recent years, seeing gains in representation and access to education among members from underserved regions. In the stew of national and regional vascular societies that dot the globe, the World…
Shape Memory Medical announces midway milestone in AAA-SHAPE randomised controlled pivotal trial
Shape Memory Medical has reached 50 per cent enrolment in its ongoing AAA-SHAPE pivotal trial, the company announced last week. AAA-SHAPE is a prospective, multicenter, randomized, open-label trial to determine safety and effectiveness of the Impede-FX RapidFill device to improve…
Randomized trial finds inferior mesenteric artery embolization ‘may not be effective’ in EVAR
Results from a multicenter randomized controlled trial (RCT) indicate that pre-emptive inferior mesenteric artery (IMA) embolisation during endovascular aneurysm repair (EVAR) does not significantly reduce aneurysm sac volume or rates of type II endoleak. The CLARIFY IMA study—which the authors…